References
- Massele A, Godman B, Adorka M, et al. Initiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):607–610.
- Gustafsson LL, Wettermark B, Godman B, et al. The ‘wise list’ – a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–233.
- Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint Hospital Primary Care Drug Recommendations Eur J Clin Pharmacol. 2013;69(Suppl 1):73–78.
- Ministry of Health and WHO. Standard treatment guidelines and essential medicines list of common medical conditions in the Kingdom of Swaziland. Available from: http://apps.who.int/medicinedocs/documents/s22119en/s22119en.pdf
- Fadare JO, Adeoti AO, Desalu OO, et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):639–650.
- Akunne OO, Godman B, Adedapo AD, et al. Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future. J Comp Eff Res. 2016;5(3):281–288.
- Mukonzo JK, Owen JS, Ogwal-Okeng J, et al. Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes. PLoS One. 2014;9(1):e86919.
- Gaida R, Truter I, Grobler C, et al. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications. Expert Rev Anti Infect Ther. 2016;14(4):377–388.
- Moon JC, Godman B, Petzold M, et al. Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Front Pharmacol. 2014;5:219.
- Godman B, Shrank W, Andersen M, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res. 2010;10(6):707–722.
- Massele A, Tiroyakgosi C, Matome M, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2016;1–4.
- Jande M, Kongola G, Mwangi JW. Drug prescribing pattern in two hospitals in Mwanza, Northwest Tanzania. East Cent Afr J Pharm Sci. 2012;15:63–68.
- Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
- Kalemeera F, Mbango C, Mubita M, et al. Effect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia. Expert Rev Anti Infect Ther. 2016;14(8):777–783.
- Membership forms MURIA. Available from: http://muria.nmmu.ac.za/Membership
- Medicines Utilisation Research in Africa – Second MURIA Training Workshop and Symposium. Available from: http://muria.nmmu.ac.za/2nd-MURIA-Training-Workshop-and-Symposium,-25-27-J